Your browser doesn't support javascript.
loading
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms.
Aldonza, Mark Borris D; Ku, Jayoung; Hong, Ji-Young; Kim, Donghwa; Yu, Seung Jung; Lee, Min-Seok; Prayogo, Monica Celine; Tan, Stephanie; Kim, Dayeon; Han, Jinju; Lee, Sang Kook; Im, Sung Gap; Ryu, Han Suk; Kim, Yoosik.
Afiliação
  • Aldonza MBD; Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Ku J; Department of Biological Sciences, KAIST, Daejeon 34141, Korea.
  • Hong JY; KI for Health Science and Technology (KIHST), KAIST, Daejeon 34141, Korea.
  • Kim D; Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Yu SJ; KI for Health Science and Technology (KIHST), KAIST, Daejeon 34141, Korea.
  • Lee MS; College of Pharmacy, Seoul National University, Seoul 08826, Korea.
  • Prayogo MC; College of Pharmacy, Seoul National University, Seoul 08826, Korea.
  • Tan S; Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Kim D; Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Han J; Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Lee SK; Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  • Im SG; Biomedical Science and Engineering Interdisciplinary Program, KAIST, Daejeon 34141, Korea.
  • Ryu HS; Biomedical Science and Engineering Interdisciplinary Program, KAIST, Daejeon 34141, Korea.
  • Kim Y; Graduate School of Medical Science and Engineering (GSMSE), KAIST, Daejeon 34141, Korea.
Sci Adv ; 6(6): eaav7416, 2020 02.
Article em En | MEDLINE | ID: mdl-32083171

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sci Adv Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Antineoplásicos Fitogênicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Sci Adv Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos